Picture of Nautilus Biotechnology logo

NAUT — Nautilus Biotechnology News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapHigh Flyer

Nautilus Biotechnology  Q2 net loss narrows as expenses drop

Overview

Nautilus Q2 2025 net loss narrows to $15 mln from $18 mln year ago

Operating expenses decreased 18% to $17.1 mln due to cost optimization

Company signed collaborations with research institutes for proteome analysis

Result Drivers

COST OPTIMIZATION - Operating expenses decreased by 18% due to cost optimization and reduced salaries and related expenses

Key Details

MetricBeat/MissActualConsensus Estimate
Q2 EPS-$0.12
Q2 Net Income-$15.03 mln
Q2 Operating Expenses$17.10 mln
Press Release: ID:nGNX5N4PS6 (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Nautilus Biotechnology

See all news